Genous TM endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study.

Trial Profile

Genous TM endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study.

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Sep 2014

At a glance

  • Drugs Anti-CD34 monoclonal antibody (Primary) ; Paclitaxel
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms TRIAS-HR-pilot
  • Most Recent Events

    • 16 Aug 2011 Two-year follow-up results published in Catheterization and Cardiovascular Interventions, according to an OrbusNeich media release.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top